University of Hertfordshire

Approaches to the Development and Use of PRO Measures: A New Roadmap

Research output: Chapter in Book/Report/Conference proceedingChapter

View graph of relations
Original languageEnglish
Title of host publicationLiving with Chronic Disease: Measuring Important Patient-Reported Outcomes
Place of PublicationSingapore
PublisherAdis
Chapter2
Pages15-49
Number of pages34
ISBN (Electronic)978-981-10-8414-0
ISBN (Print)978-981-10-8413-3
DOIs
Publication statusPublished - 7 Sep 2018

Abstract

Various recent developments are driving an evolution in the way PRO measures are developed. For example, drug regulatory agencies (e.g. the FDA) can now be more substantively involved or consulted on measure development work; the patients’ role is now seen as going beyond being a study subject to being involved as research partners. Use of modern test theory in development of scoring algorithms and overall measure development work is now the new ‘gold standard’.

ID: 15415526